RNAi for Therapeutic

Global RNAi for Therapeutic Market Data Survey Report 2013-2025

Report ID: HeyReport 17391 | Number of pages: 66 | Publish Date: Mar 2019 | Category: Lifesciences and Healthcare 
Summary
RNA interference (RNAi) is a biological process in which RNA molecules inhibit gene expression, typically by causing the destruction of specific mRNA molecules. Historically, it was known by other names, including co-suppression, post-transcriptional gene silencing (PTGS), and quelling. Only after these apparently unrelated processes were fully understood did it become clear that they all described the RNAi phenomenon. RNAi is now known as precise, efficient, stable and better than antisense technology for gene suppression.
The global RNAi for Therapeutic market will reach xxx Million USD in 2019 with CAGR xx% 2019-2025. The main contents of the report including:
Global market size and forecast
Regional market size, production data and export & import
Key manufacturers profile, products & services, sales data of business
Global market size by Major Application
Global market size by Major Type
Key manufacturers are included based on company profile, sales data and product specifications etc.:
    Alnylam Pharmaceuticals
    Arrowhead
    Dicerna Pharmaceuticals
    Mirna Therapeutics
    Quark Pharmaceuticals
    RXi Pharmaceuticals
    miRagen Therapeutics
    Gradalis
    Sirnaomics
Major applications as follows:
    Cancer
    Cardiovascular
    HBV
    Others
Major Type as follows:
    siRNA
    miRNA
    shRNA
Regional market size, production data and export & import:
    Asia-Pacific
    North America
    Europe
    South America
    Middle East & Africa
Interested in this report?
Get your sample now!
Download Sample 
Table of Contents
1 Global Market Overview
    1.1 Scope of Statistics
        1.1.1 Scope of Products
        1.1.2 Scope of Manufacturers
        1.1.3 Scope of Application
        1.1.4 Scope of Type
        1.1.5 Scope of Regions/Countries
    1.2 Global Market Size
2 Regional Market
    2.1 Regional Production
    2.2 Regional Demand
    2.3 Regional Trade
3 Key Manufacturers
    3.1 Alnylam Pharmaceuticals
        3.1.1 Company Information
        3.1.2 Product & Services
        3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
        3.1.4 Recent Development
    3.2 Arrowhead
        3.2.1 Company Information
        3.2.2 Product & Services
        3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
        3.2.4 Recent Development
    3.3 Dicerna Pharmaceuticals
        3.3.1 Company Information
        3.3.2 Product & Services
        3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
        3.3.4 Recent Development
    3.4 Mirna Therapeutics
        3.4.1 Company Information
        3.4.2 Product & Services
        3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
        3.4.4 Recent Development
    3.5 Quark Pharmaceuticals
        3.5.1 Company Information
        3.5.2 Product & Services
        3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
        3.5.4 Recent Development
    3.6 RXi Pharmaceuticals
        3.6.1 Company Information
        3.6.2 Product & Services
        3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
        3.6.4 Recent Development
    3.7 miRagen Therapeutics
        3.7.1 Company Information
        3.7.2 Product & Services
        3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
        3.7.4 Recent Development
    3.8 Gradalis
        3.8.1 Company Information
        3.8.2 Product & Services
        3.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
    3.9 Sirnaomics
        3.9.1 Company Information
        3.9.2 Product & Services
        3.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
4 Major Application
    4.1 Cancer
        4.1.1 Overview
        4.1.2 Cancer Market Size and Forecast
    4.2 Cardiovascular
        4.2.1 Overview
        4.2.2 Cardiovascular Market Size and Forecast
    4.3 HBV
        4.3.1 Overview
        4.3.2 HBV Market Size and Forecast
    4.4 Others
        4.4.1 Overview
        4.4.2 Others Market Size and Forecast
5 Market by Type
    5.By siRNA
    5.1 siRNA
        5.1.1 Overview
        5.1.2 siRNA Market Size and Forecast
    5.2 miRNA
        5.2.1 Overview
        5.2.2 miRNA Market Size and Forecast
    5.3 shRNA
        5.3.1 Overview
        5.3.2 shRNA Market Size and Forecast
6 Price Overview
    6.1 Price by Manufacturers
    6.2 Price by Application
    6.3 Price by Type
7 Conclusion
Tab Regional Production 2013-2018 (Million USD)
Tab Regional Production 2013-2018 (Volume)
Tab Regional Demand and CAGR 2013-2018 (Million USD)
Tab Regional Demand and CAGR 2013-2018 (Volume)
Tab Regional Demand Forecast and CAGR 2019-2025 (Million USD)
Tab Regional Demand Forecast and CAGR 2019-2025 (Volume)
Tab Regional Export 2013-2018 (Million USD)
Tab Regional Export 2013-2018 (Volume)
Tab Regional Import 2013-2018 (Million USD)
Tab Regional Import 2013-2018 (Volume)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Alnylam Pharmaceuticals
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Arrowhead
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Dicerna Pharmaceuticals
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Mirna Therapeutics
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Quark Pharmaceuticals
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of RXi Pharmaceuticals
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of miRagen Therapeutics
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Gradalis
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Sirnaomics

Fig Global RNAi for Therapeutic Market Size and CAGR 2013-2018 (Million USD)
Fig Global RNAi for Therapeutic Market Size and CAGR 2013-2018 (Volume)
Fig Global RNAi for Therapeutic Market Forecast and CAGR 2019-2025 (Million USD)
Fig Global RNAi for Therapeutic Market Forecast and CAGR 2019-2025 (Volume)
Fig Cancer Market Size and CAGR 2013-2018 (Million USD)
Fig Cancer Market Size and CAGR 2013-2018 (Volume)
Fig Cancer Market Forecast and CAGR 2019-2025 (Million USD)
Fig Cancer Market Forecast and CAGR 2019-2025 (Volume)
Fig Cardiovascular Market Size and CAGR 2013-2018 (Million USD)
Fig Cardiovascular Market Size and CAGR 2013-2018 (Volume)
Fig Cardiovascular Market Forecast and CAGR 2019-2025 (Million USD)
Fig Cardiovascular Market Forecast and CAGR 2019-2025 (Volume)
Fig HBV Market Size and CAGR 2013-2018 (Million USD)
Fig HBV Market Size and CAGR 2013-2018 (Volume)
Fig HBV Market Forecast and CAGR 2019-2025 (Million USD)
Fig HBV Market Forecast and CAGR 2019-2025 (Volume)
Fig Others Market Size and CAGR 2013-2018 (Million USD)
Fig Others Market Size and CAGR 2013-2018 (Volume)
Fig Others Market Forecast and CAGR 2019-2025 (Million USD)
Fig Others Market Forecast and CAGR 2019-2025 (Volume)
Fig siRNA Market Size and CAGR 2013-2018 (Million USD)
Fig siRNA Market Size and CAGR 2013-2018 (Volume)
Fig siRNA Market Forecast and CAGR 2019-2025 (Million USD)
Fig siRNA Market Forecast and CAGR 2019-2025 (Volume)
Fig miRNA Market Size and CAGR 2013-2018 (Million USD)
Fig miRNA Market Size and CAGR 2013-2018 (Volume)
Fig miRNA Market Forecast and CAGR 2019-2025 (Million USD)
Fig miRNA Market Forecast and CAGR 2019-2025 (Volume)
Fig shRNA Market Size and CAGR 2013-2018 (Million USD)
Fig shRNA Market Size and CAGR 2013-2018 (Volume)
Fig shRNA Market Forecast and CAGR 2019-2025 (Million USD)
Fig shRNA Market Forecast and CAGR 2019-2025 (Volume)